Latest Tenpoint Therapeutics News & Updates
See the latest news and media coverage for Tenpoint Therapeutics. We track all announcements, press releases, and industry mentions in real time, all in one place.
Eye therapeutics developer for aging vision disorders
tenpointtherapeutics.com- Headquarters
- Irvine, United States
- Founded year
- 2019
- Company type
- Private company
- Number of employees
- 125–200
Last updated
Latest news about Tenpoint Therapeutics
Company announcements
-
Tenpoint Therapeutics welcomes Dr. Stephen Lane as Chief Medical Officer
Dr. Lane brings extensive ophthalmology experience. He oversees clinical development, medical affairs, and pharmacovigilance.
-
Tenpoint Therapeutics announces YUVEZZI™ availability in U.S.
YUVEZZI™ is carbachol and brimonidine tartrate ophthalmic solution 2.75%/0.1%.
-
Tenpoint Therapeutics announces YUVEZZI™ availability in U.S.
YUVEZZI™ is carbachol and brimonidine tartrate ophthalmic solution 2.75%/0.1%.
-
Tenpoint Therapeutics announces FDA approval of YUVEZZI
YUVEZZI is the first dual-agent eye drop for presbyopia treatment, based on Phase 3 trials, available Q2 2026.
Media coverage
-
Ritedose Announces Manufacturing for Tenpoint Therapeutics' Presbyopia Eye Drop
The Ritedose Corporation, Inc. (Ritedose), the largest contract development manufacturing organization (CDMO) in the United States specializing in sterile Blow-Fill-Seal (BFS) production of unit dose...
-
Tenpoint Therapeutics, Ltd. Appoints Stephen S. Lane, M.D., as Chief Medical Officer
Tenpoint Therapeutics, Ltd., a global commercial ophthalmic pharmaceutical company focused on developing groundbreaking treatments to improve vision in the aging eye, today announced the appointment...
-
Tenpoint Therapeutics Ltd and PHIL Partner to Launch YUVEZZI™ Direct-to-Patient Cash Program to Make Novel Presbyopia Therapy More Accessible and Affordable
Tenpoint Therapeutics, a leading ophthalmic manufacturer, and PHIL Inc., an all-in-one digital hub and Direct-to-Patient platform, today announced the launch of a Direct-to-Patient (DTP) cash...
-
YUVEZZI™ from Tenpoint Therapeutics, Ltd. Is Now Available Nationwide Across the United States
Tenpoint Therapeutics, Ltd., a global, commercial-stage ophthalmic pharmaceutical company focused on developing groundbreaking treatments to improve vision in the aging eye, today announced that YUVEZZI...
Track Tenpoint Therapeutics and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Trending companies
Discover what's making headlines across other trending companies.
Pit
Davis AI
Qutwo
DigiPowerX
Penguin Solutions
Sterling Infrastructure
KIOXIA Corporation
Subquadratic
Tibber
IREN
A24
Hitachi Energy
Ouster
Ormat Technologies
Fabrinet
AOI
WidePoint
Filtronic
Mirum Pharmaceuticals
Capstone Green Energy
AXT
POET Technologies
PurpleFire
Profitable Media
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze
Optimove
Bluecore